NCT01219868

Brief Summary

The objective of this study is to explore the impact of a physician-nurse team supervising patient's flow on ED length of stay

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
8,000

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Oct 2010

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2010

Completed
5 days until next milestone

First Submitted

Initial submission to the registry

October 6, 2010

Completed
7 days until next milestone

First Posted

Study publicly available on registry

October 13, 2010

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2011

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2011

Completed
Last Updated

March 20, 2013

Status Verified

March 1, 2013

Enrollment Period

3 months

First QC Date

October 6, 2010

Last Update Submit

March 19, 2013

Conditions

Outcome Measures

Primary Outcomes (1)

  • ED length of stay

    3 months

Study Arms (1)

Physician-nurse team

EXPERIMENTAL
Behavioral: Physician-nurse team supervision

Interventions

Physician-nurse team will supervise patient's flow in the ED

Also known as: No name
Physician-nurse team

Eligibility Criteria

Age16 Years+
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • all adult patients \> 16 years presenting to the ED

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

ED of Geneva University Hospitals

Geneva, Canton of Geneva, 1211, Switzerland

Location

Study Officials

  • Olivier T Rutschmann, MD, MPH

    HUG

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD, MPH

Study Record Dates

First Submitted

October 6, 2010

First Posted

October 13, 2010

Study Start

October 1, 2010

Primary Completion

January 1, 2011

Study Completion

March 1, 2011

Last Updated

March 20, 2013

Record last verified: 2013-03

Locations